U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07194941) titled 'Efficacy and Safety of Fecal Microbiota Transfer (FMT) for Recurrent Urinary Tract Infections in Women' on Sept. 19.
Brief Summary: Urinary tract infections (UTIs) are highly prevalent worldwide, especially in women, with frequent recurrences and significant healthcare costs. The proposed Phase II clinical trial will define dosing and administration strategies for FMT in recurrent UTIs. If effective, this ecological approach could provide a novel therapeutic alternative to antibiotics for one of the most common infectious diseases worldwide
Study Start Date: Aug. 25, 2022
Study Type: INTERVENTIONAL
Condition:
Recurrent Urinary ...